Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03558204 · ClinicalTrials.gov registry record

Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy

A clinical trial of Thumb Osteoarthritis, sponsored by Johns Hopkins University.

Completed
Registry status
53
Enrollment target
1
Study location

NCT03558204: Completed study of Thumb Osteoarthritis, sponsored by Johns Hopkins University.

NCT03558204 is a study of Thumb Osteoarthritis that has completed, run by Johns Hopkins University. The registered enrollment target is 53 participants, below the 113-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03558204, a study of Thumb Osteoarthritis, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
53 participants
Enrollment target
1
Study location

Study Summary

This is a prospective study tracking the outcomes of patients who undergo either of two treatments for thumb carpo-metacarpal joint arthritis: trapeziectomy with ligament reconstruction (LRTI) or denervation.

Primary Outcome

brief Michigan Hand Questionnaire (MHQ). (score ranges from 0 to 100, lower score indicates better function)

Conditions Studied

Interventions

  • PROCEDURE Denervation of the thumb CMC joint
  • PROCEDURE trapeziectomy with ligament reconstruction (LRTI)

Study Locations (1)

Maryland

  • Johns Hopkins Bayview Medical Center - Baltimore

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2018-08-01
Est. Completion 2023-01-30
Johns Hopkins University

1,448 total trials

What the finished NCT03558204 record still lists

NCT03558204 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 113-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (53% lower).

The record links to 1 condition, with Thumb Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Denervation of the thumb CMC joint is the first listed.

NCT03558204 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT03558204 about?

NCT03558204 is a clinical study titled "Thumb Carpometacarpal Joint Denervation Versus Trapeziectomy". This is a prospective study tracking the outcomes of patients who undergo either of two treatments for thumb carpo-metacarpal joint arthritis: trapeziectomy with ligament reconstruction (LRTI) or denervation.

What is the current status of trial NCT03558204?

This trial is currently completed. The enrollment target is 53 participants. The study started on 2018-08-01. Estimated completion is 2023-01-30.

What conditions does trial NCT03558204 study?

This clinical trial studies the following conditions: Thumb Osteoarthritis.

What interventions are being tested in trial NCT03558204?

The interventions under investigation include: Denervation of the thumb CMC joint (PROCEDURE), trapeziectomy with ligament reconstruction (LRTI) (PROCEDURE).

Who is sponsoring clinical trial NCT03558204?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03558204 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thumb Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03558204, the US trial registry maintained by the National Library of Medicine. NCT03558204 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.